• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Sino-Nasal Outcome Test-22: 波兰语患者的翻译、跨文化调适和验证。

Sino-Nasal Outcome Test-22: translation, cross-cultural adaptation, and validation in Polish-speaking patients.

机构信息

Department of Otolaryngology, Head and Neck Oncology, Medical University of Lodz, Łódź, Poland.

Department of Electromagnetic Hazards, Nofer Institute of Occupational Medicine, Łódź, Poland.

出版信息

Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6431-6443. doi: 10.1007/s00405-024-08919-z. Epub 2024 Aug 28.

DOI:10.1007/s00405-024-08919-z
PMID:39198305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11564299/
Abstract

PURPOSE

There are many specific instruments for assessing the quality of life (QoL) in patients with chronic rhinosinusitis. Of all these tests, the Sino-Nasal Outcome Test-22 (SNOT-22) is the most widely used internationally. The purpose of the study was linguistic adaptation and validation of the SNOT-22 scale in the Polish language.

METHODS

The SNOT-22 was adapted into Polish and was administered to 148 subjects (108 patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and 40 asymptomatic controls. Seventy-one patients completed the SNOT-22 a second time to evaluate test-retest reliability. The Polish SNOT-22 was assessed for internal consistency, test-retest reliability, discriminant validity, criterion validity, and sensitivity and specificity.

RESULTS

The Polish SNOT-22 exhibited satisfactory psychometric properties. A high Cronbach's alpha coefficient (α = 0.89) was obtained. Significantly higher scores (p < 0.01) were revealed in the Study Group with a median score of 32 (range 15-53) points in comparison with controls: 5 (range 0-20). A moderate correlation was found between SNOT-22 and the Lund-Kennedy test score (r = 0.334; p < 0.001) and a strong correlation between SNOT-22 and the Lund-Macay test score (r = 0.469; p < 0.001). The best cut-off point was set at a 16 score with a sensitivity of 0.981 and a specificity of 0.995. The determined Area Under Curve (AUC = 0.997; p < 0.001) confirms the diagnostic accuracy of the Polish SNOT-22.

CONCLUSIONS

The Polish version of the SNOT-22 is a valid and reliable tool for measuring health-related quality of life in patients with CRSwNP in the Polish-speaking population.

摘要

目的

有许多专门的工具可用于评估慢性鼻-鼻窦炎(CRS)患者的生活质量(QoL)。在所有这些测试中,Sino-Nasal Outcome Test-22(SNOT-22)是国际上应用最广泛的。本研究的目的是对 SNOT-22 量表进行波兰语的语言适应性和验证。

方法

SNOT-22 被改编成波兰语,并对 148 名受试者(108 名患有鼻息肉的慢性鼻-鼻窦炎患者(CRSwNP)和 40 名无症状对照者)进行了测试。71 名患者完成了 SNOT-22 的第二次测试,以评估测试-重测信度。对波兰 SNOT-22 进行了内部一致性、测试-重测信度、判别有效性、标准有效性以及敏感性和特异性的评估。

结果

波兰 SNOT-22 表现出良好的心理测量特性。Cronbach's alpha 系数(α=0.89)较高。与对照组(中位数为 32 分,范围为 15-53 分)相比,研究组的得分显著更高(p<0.01),中位数为 5 分(范围为 0-20 分)。SNOT-22 与 Lund-Kennedy 测试评分之间存在中度相关性(r=0.334;p<0.001),与 Lund-Macay 测试评分之间存在强相关性(r=0.469;p<0.001)。最佳截断值设定为 16 分,灵敏度为 0.981,特异性为 0.995。确定的曲线下面积(AUC=0.997;p<0.001)证实了波兰 SNOT-22 的诊断准确性。

结论

波兰版 SNOT-22 是一种有效的、可靠的工具,可用于评估波兰语人群中 CRSwNP 患者的健康相关生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/bb6ac354f443/405_2024_8919_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/0adfe8b2bf84/405_2024_8919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/d242aa55e304/405_2024_8919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/bb6ac354f443/405_2024_8919_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/0adfe8b2bf84/405_2024_8919_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/d242aa55e304/405_2024_8919_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65e6/11564299/bb6ac354f443/405_2024_8919_Fig3_HTML.jpg

相似文献

1
Sino-Nasal Outcome Test-22: translation, cross-cultural adaptation, and validation in Polish-speaking patients.Sino-Nasal Outcome Test-22: 波兰语患者的翻译、跨文化调适和验证。
Eur Arch Otorhinolaryngol. 2024 Dec;281(12):6431-6443. doi: 10.1007/s00405-024-08919-z. Epub 2024 Aug 28.
2
Assessment of health-related quality-of-life in patients with chronic Rhinosinusitis - Validation of the German Sino-Nasal Outcome Test-22 (German-SNOT-22).慢性鼻-鼻窦炎患者健康相关生活质量评估——德国鼻-鼻窦结局测试 22 项(German-SNOT-22)的验证。
J Psychosom Res. 2021 Jan;140:110316. doi: 10.1016/j.jpsychores.2020.110316. Epub 2020 Nov 24.
3
Sino-Nasal Outcome Test-22: Translation, Cross-cultural Adaptation, and Validation in Hebrew-Speaking Patients.鼻-鼻窦结局测试-22:在说希伯来语患者中的翻译、跨文化调适及验证
Otolaryngol Head Neck Surg. 2016 May;154(5):951-6. doi: 10.1177/0194599816629378. Epub 2016 Feb 23.
4
Sino-nasal outcome test-22: Cross-cultural adaptation and validation in Russian speaking patients.Sino-nasal outcome test-22: 俄语患者的跨文化调适与验证。
Clin Otolaryngol. 2020 May;45(3):350-356. doi: 10.1111/coa.13505. Epub 2020 Feb 6.
5
Cross-cultural adaptation and validation of the sino-nasal outcome test (SNOT-22) for Spanish-speaking patients.针对说西班牙语患者的鼻鼻窦结局测试(SNOT-22)的跨文化调适与验证。
Eur Arch Otorhinolaryngol. 2015 Nov;272(11):3335-40. doi: 10.1007/s00405-014-3437-0. Epub 2014 Dec 16.
6
Mepolizumab improvements in health-related quality of life and disease symptoms in a patient population with very severe chronic rhinosinusitis with nasal polyps: psychometric and efficacy analyses from the SYNAPSE study.美泊利珠单抗改善伴有鼻息肉的重度慢性鼻-鼻窦炎患者的健康相关生活质量和疾病症状:SYNAPSE 研究的心理测量学和疗效分析。
J Patient Rep Outcomes. 2023 Jan 20;7(1):4. doi: 10.1186/s41687-023-00543-5.
7
The sino-nasal outcome test (SNOT)-22: validation for Greek patients.鼻窦结局测试(SNOT)-22:针对希腊患者的验证
Eur Arch Otorhinolaryngol. 2014 Oct;271(10):2723-8. doi: 10.1007/s00405-014-2969-7. Epub 2014 Mar 5.
8
Development, reliability, validity and sensitivity of the Sino-Nasal Outcome Test for Neurosurgery (SNOT-NC).《神经外科鼻颅底结局测试量表(SNOT-NC)的研制、信度、效度和灵敏度》
Eur Arch Otorhinolaryngol. 2020 Jan;277(1):235-244. doi: 10.1007/s00405-019-05661-9. Epub 2019 Sep 26.
9
Development of Sinonasal Outcome Test (SNOT-22) Domains in Chronic Rhinosinusitis With Nasal Polyps.慢性鼻-鼻窦炎伴鼻息肉患者的鼻-鼻窦结局测试(SNOT-22)领域的开发。
Laryngoscope. 2022 May;132(5):933-941. doi: 10.1002/lary.29766. Epub 2021 Aug 26.
10
Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study.跨文化调适与验证 22 项鼻窦结局测试(SNOT-22)于德语族群患者:前瞻性、多中心队列研究。
Eur Arch Otorhinolaryngol. 2022 May;279(5):2433-2439. doi: 10.1007/s00405-021-07019-6. Epub 2021 Aug 5.

引用本文的文献

1
Mechanisms of Neuronal Differentiation and Notch Signaling as a Potential Therapeutic Target in Olfactory Dysfunction of Allergic Rhinitis.神经元分化机制及Notch信号通路作为变应性鼻炎嗅觉功能障碍潜在治疗靶点的研究
J Inflamm Res. 2025 Apr 16;18:5097-5109. doi: 10.2147/JIR.S504050. eCollection 2025.

本文引用的文献

1
Biologics for Chronic Rhinosinusitis-A Modern Option for Therapy.用于慢性鼻-鼻窦炎的生物制剂——一种现代治疗选择
Life (Basel). 2023 Nov 5;13(11):2165. doi: 10.3390/life13112165.
2
Recent guidelines addressing chronic rhinosinusitis with nasal polyps: practical aspects.近期关于伴有鼻息肉的慢性鼻-鼻窦炎的治疗指南:实用方面。
Pol Arch Intern Med. 2023 Nov 29;133(11). doi: 10.20452/pamw.16611. Epub 2023 Nov 21.
3
5-Item sino-nasal outcome test and 22-item sino-nasal outcome test relationship with endoscopic and radiologic scores in chronic rhinosinusitis with nasal polyps.
5 项鼻窦结局测试和 22 项鼻窦结局测试与鼻息肉慢性鼻窦炎的内镜和影像学评分的关系。
Ann Allergy Asthma Immunol. 2024 Mar;132(3):363-367. doi: 10.1016/j.anai.2023.11.011. Epub 2023 Nov 19.
4
Biological Treatment for Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: Preliminary Real-World Results from a Tertiary Medical Center.生物治疗难治性慢性鼻-鼻窦炎伴鼻息肉:来自三级医疗中心的初步真实世界结果
J Clin Med. 2023 May 25;12(11):3671. doi: 10.3390/jcm12113671.
5
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.2023 年 EPOS/EUFOREA 关于生物制剂治疗慢性鼻-鼻窦炎伴鼻息肉的适应证和评估的更新。
Rhinology. 2023 Jun 1;61(3):194-202. doi: 10.4193/Rhin22.489.
6
Interpreting area under the receiver operating characteristic curve.解读受试者工作特征曲线下的面积
Lancet Digit Health. 2022 Dec;4(12):e853-e855. doi: 10.1016/S2589-7500(22)00188-1. Epub 2022 Oct 18.
7
Clinical symptoms of chronic rhinosinusitis with nasal polyps (eosinophilic and non-eosinophilic) are related to sinus computed tomography but not to endoscopic findings.慢性鼻-鼻窦炎伴鼻息肉(嗜酸性和非嗜酸性)的临床症状与鼻窦计算机断层扫描有关,但与内镜检查结果无关。
Acta Otorrinolaringol Esp (Engl Ed). 2022 Jul-Aug;73(4):203-209. doi: 10.1016/j.otoeng.2021.03.004.
8
Epidemiology of Chronic Rhinosinusitis: Prevalence and Risk Factors.慢性鼻-鼻窦炎的流行病学:患病率和危险因素。
J Allergy Clin Immunol Pract. 2022 Jun;10(6):1395-1403. doi: 10.1016/j.jaip.2022.01.016. Epub 2022 Jan 29.
9
Cross-cultural adaptation and validation of the 22-item sinonasal outcome test (SNOT-22) in German-speaking patients: a prospective, multicenter cohort study.跨文化调适与验证 22 项鼻窦结局测试(SNOT-22)于德语族群患者:前瞻性、多中心队列研究。
Eur Arch Otorhinolaryngol. 2022 May;279(5):2433-2439. doi: 10.1007/s00405-021-07019-6. Epub 2021 Aug 5.
10
Translation, cross-cultural adaptation, and validation of the sino-nasal outcome test (snot)-22 for Finnish patients.中文译文:芬兰患者的 SNOT-22 中文版的翻译、跨文化调适和验证。
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):405-410. doi: 10.1007/s00405-020-06297-w. Epub 2020 Aug 20.